CH9

General Information


DRACP ID  DRACP03771

Peptide Name   CH9

Sequence  WKLLSKAQEKFGKNKSR,RYGTXIYQXRLWAFSK

Sequence Length  34

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C178H271N51O40

Absent amino acids  CDHMPV

Common amino acids  K

Mass  457420

Pl  11.43

Basic residues  9

Acidic residues  1

Hydrophobic residues  10

Net charge  8

Boman Index  -7984

Hydrophobicity  -100.29

Aliphatic Index  51.76

Half Life 
  /

Extinction Coefficient cystines  13980

Absorbance 280nm  423.64

Polar residues  9

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30048118

Title  Antimicrobial Activity of Chimera Peptides Composed of Human Neutrophil Peptide 1 (HNP-1) Truncated Analogues and Bovine Lactoferrampin

Doi Not available

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  12433

DRACP is developed by Dr.Zheng's team.